Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (30 September 2016)
Bagsværd, Denmark, 3 October 2016 - In continuation of the company's announcements dated 3 February 2016 and 5 August 2016 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2016 owned 29,476,648 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,895,330 or 1.2% of the total share capital.
In the third quarter of 2016 a total of 11,107,003 B shares were repurchased, and 8,000 B shares were disposed to employees in connection with employee incentive programmes.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | amhg@novonordisk.com |
| Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
| Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com |
| Hanna Ögren | +45 3079 8519 | haoe@novonordisk.com |
| Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Company announcement No 68/2016
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
\Hugin